骨肉瘤患者的病理性骨折与更差的生存结局相关吗?一项系统综述与Meta分析
该系统综述与Meta分析纳入21项研究、共7604例骨肉瘤患者(其中12%即885例发生病理性骨折),评估病理性骨折与总生存、局部复发、无转移生存及手术方式的关系。结果显示病理性骨折与较低的3年和5年总生存率以及较高的转移风险相关,但与局部复发率无显著差异;保肢手术与截肢手术的局部复发率无显著差异。
要点
- 骨肉瘤合并病理性骨折与更低的3年总生存(RR 1.53)和5年总生存(RR 1.27)相关。
- 病理性骨折增加转移风险(RR 1.33),但局部复发率与无骨折者无显著差异(RR 1.22)。
- 保肢手术与截肢手术的局部复发率无显著差异(RR 1.58),病理性骨折可能不再是保肢的绝对禁忌证。
核心结论
- 骨肉瘤患者的病理性骨折与更低的总生存率和更高的转移风险相关,但与局部复发率无显著关联。
- 经过适当的病例选择,骨肉瘤合并病理性骨折患者行保肢手术的局部复发率可能与截肢手术相似,病理性骨折可能不再是保肢手术的绝对禁忌证。
- 未来需要调整肿瘤大小、肿瘤位置和新辅助治疗反应等潜在混杂因素的研究,以进一步阐明病理性骨折对评估结局的影响。
研究设计与样本
- 系统综述与Meta分析,遵循PRISMA指南,研究注册于PROSPERO(ID: 380459)。
- 检索PubMed和Embase数据库分别获得625和747条题录,最终纳入21篇文章。
- 使用纽卡斯尔-渥太华质量评估量表进行质量评价,对11篇评估干预(截肢或保肢)对局部复发率影响的研究使用非随机干预研究偏倚风险工具。
- 共纳入7604例骨肉瘤患者,其中12%(885例)发生病理性骨折。
- 计算相对危险度(RR)比较合并病理性骨折与未合并病理性骨折患者的结局,使用I²统计量评估异质性,根据异质性选择固定效应或随机效应模型计算合并RR,并计算脆弱指数及脆弱指数与各结局总参与者数的比值以评估结果的稳健性。
主要发现
- 骨肉瘤合并病理性骨折与较低的3年总生存率相关(RR 1.53 [95% CI 1.29至1.82];p < 0.001)。
- 骨肉瘤合并病理性骨折与较低的5年总生存率相关(RR 1.27 [95% CI 1.16至1.40];p < 0.001)。
- 合并病理性骨折与未合并病理性骨折的骨肉瘤患者复发率无差异(RR 1.22 [95% CI 0.91至1.64];p = 0.18)。
- 合并病理性骨折与发生转移风险增加相关(RR 1.33 [95% CI 1.08至1.63];p = 0.01)。
- 保肢手术治疗与更高的局部复发率无关(RR 1.58 [95% CI 0.88至2.85];p = 0.13)。
关键数值与推荐
- 病理性骨折与3年总生存率降低相关(RR 1.53 [95% CI 1.29至1.82];p < 0.001)。
- 病理性骨折与5年总生存率降低相关(RR 1.27 [95% CI 1.16至1.40];p < 0.001)。
- 病理性骨折与复发率无显著差异(RR 1.22 [95% CI 0.91至1.64];p = 0.18)。
- 病理性骨折与转移风险增加相关(RR 1.33 [95% CI 1.08至1.63];p = 0.01)。
- 保肢手术与局部复发率无显著差异(RR 1.58 [95% CI 0.88至2.85];p = 0.13)。
临床怎么用
- 作者认为,外科医生应意识到,经过适当的病例选择,骨肉瘤合并病理性骨折患者行保肢手术的局部复发率可能与截肢手术相似。
- 作者认为,病理性骨折可能不再是保肢手术的绝对禁忌证。
局限性
- 未来需要调整肿瘤大小、肿瘤位置和新辅助治疗反应等潜在混杂因素的研究,以进一步阐明病理性骨折对评估结局的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pathologic fractures occur in 5% to 10% of patients with osteosarcoma, and prior studies have suggested they are prognostically important. However, because they represent an uncommon event in the setting of an already rare disease, most studies fail to reach conclusive findings, and there is no agreement about how best to treat pathologic fractures. QUESTIONS/PURPOSES: (1) Is the occurrence of a pathologic fracture in patients with osteosarcoma associated with poorer overall survivorship? (2) Is the occurrence of a pathologic fracture in patients with osteosarcoma associated with poorer local recurrence-free survival or metastasis-free survival? (3) Is the surgical approach (amputation or limb salvage) associated with differences in local recurrence rates in patients with osteosarcoma with pathologic fractures? METHODS: This systematic review was performed following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Our study was registered in PROSPERO (ID: 380459). A search of the PubMed and Embase databases resulted in 625 and 747 titles, respectively. After application of the inclusion and exclusion criteria, 21 articles were finally included. Quality assessment of all studies was performed using the Newcastle-Ottawa Quality Assessment Scale. The Risk of Bias In Non-Randomized Studies of Interventions tool was used in the 11 articles that evaluated the effect of an intervention (amputation or limb salvage) on local recurrence rates. The relative risk (RR) was calculated to compare outcomes in patients with osteosarcoma with pathologic fractures and those without. Heterogeneity among studies was calculated using the I 2 statistic. The pooled RR was calculated using the fixed-effects or random-effects model depending on study heterogeneity. The fragility index and the ratio between the fragility index and the total number of participants for each outcome was additionally calculated to assess the robustness of our results. A total of 7604 patients with osteosarcoma, 12% of whom (885) had pathologic fractures, were included in our analysis. RESULTS: Pathologic fractures in patients with osteosarcoma were associated with lower 3-year (RR 1.53 [95% CI 1.29 to 1.82]; p < 0.001) and 5-year overall survival (RR 1.27 [95% CI 1.16 to 1.40]; p < 0.001). No difference in recurrence rates was found between patients with osteosarcoma with pathologic fractures and those without (RR 1.22 [95% CI 0.91 to 1.64]; p = 0.18). However, having a pathologic fracture was associated with an increased risk of developing metastasis (RR 1.33 [95% CI 1.08 to 1.63]; p = 0.01). Treatment with limb salvage surgery was not associated with a higher rate of local recurrence (RR 1.58 [95% CI 0.88 to 2.85]; p = 0.13). CONCLUSION: In light of these findings, surgeons should be aware that after appropriate case selection, patients with osteosarcoma and pathologic fractures undergoing limb salvage surgery may have similar rates of local recurrence to those undergoing amputation. Therefore, a pathologic fracture may no longer be an absolute contraindication for limb salvage surgery. Future studies adjusting for potential confounders such as tumor size, tumor location, and response to neoadjuvant therapy would provide further insight into the effect of pathologic fractures on our assessed outcomes. LEVEL OF EVIDENCE: Level III, therapeutic study.
引用
- Gonzalez MR, Bedi A, Karczewski D, et al. Are Pathologic Fractures in Patients With Osteosarcoma Associated With Worse Survival Outcomes? A Systematic Review and Meta-analysis. Clin Orthop Relat Res. 2023. PMID: 37184541. doi:10.1097/CORR.0000000000002687
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。